-
Mashup Score: 0Fixed-Dose Macitentan/Tadalafil Combo Gets FDA Approval for PAH - 2 month(s) ago
Opsynvi puts two drugs commonly prescribed for pulmonary arterial hypertension into one tablet
Source: www.medpagetoday.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 8
/PRNewswire/ — Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today…
Source: www.prnewswire.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0FDA advisory panel votes in favor of Abbott’s TriClip device for tricuspid regurgitation - 3 month(s) ago
After hours of discussion, the panel determined that the benefits of using the TriClip G4 TEER system to treat TR outweigh any potential risks.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Total artificial hearts: Exploring the future of heart transplant technology with a renowned surgeon - 3 month(s) ago
Francisco Arabia, MD, spoke with Cardiovascular Business about the present and future of total artificial heart technology.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2Edwards makes history, receives FDA approval for transcatheter tricuspid valve replacement device - 3 month(s) ago
The approval, based on positive results from the TRISCEND II trial, represents a significant milestone for the treatment of severe tricuspid regurgitation.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2Edwards makes history, receives FDA approval for transcatheter tricuspid valve replacement device - 3 month(s) ago
The approval, based on positive results from the TRISCEND II trial, represents a significant milestone for the treatment of severe tricuspid regurgitation.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 4
January 9, 2023 — When we were little, our parents told us to take our vitamins so we could grow big and strong. Now, researchers from Japan find that one particular supplement may even fix a broken heart. In a study that published recently in European Heart Journal, researchers from Osaka University have revealed that a dietary supplement can dramatically reverse the signs of heart disease in a subset of patients. Coronary artery disease (CAD), which involves narrowing or even closing of the arteries of the heart and often leads to heart attack, is a major cause of death worldwide. Despite the existence of treatments such as cholesterol-lowering drugs and drug-eluting stents—a new stent technology for local drug delivery—death from this condition is still common, and some patients appear to be resistant to treatment. “Almost 15 years ago we identified a new type of CAD called triglyceride deposit cardiomyovasculopathy (TGCV), in which the coronary arteries are occluded by triglyceride
Source: www.dicardiology.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 13D Printing for Left Ventricular Assist Device Exchange: Insights From Real-World Experience - 4 month(s) ago
Left ventricular assist devices (LVADs) are used in end-stage heart failure. Inadequate positioning of the inflow cannula may necessitate replacement …
Source: www.sciencedirect.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
The device is intended to be a bridge for heart failure patients waiting to receive a full heart transplant.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0‘A true breakthrough’: The eye-opening potential of GLP-1 agonists to treat heart, kidney disease in addition to obesity - 5 month(s) ago
While GLP-1 drugs were originally developed to treat diabetes, researchers keep finding additional ways these medications can potentially benefit patients.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
Based on phase III A DUE trial. Fixed-Dose Macitentan/Tadalafil Combo Gets FDA Approval for PAH https://t.co/uqP9PM9qlI